ABSTRACT
Few data are available focusing on controlled blunt microdissection during below-the-knee interventions as sole or synchronous technique coupled to subintimal angioplasty, particularly in the management of diabetic critical-ischemic foot wounds. We present two cases of targeted recanalizations in the tibial and pedal trunks for plantar and forefoot diabetic ischemic tissue defects, following an angiosome-model for perfusion.
Subject(s)
Angioplasty/methods , Foot Ulcer/surgery , Foot/blood supply , Ischemia/surgery , Microdissection/methods , Tibial Arteries/surgery , Tunica Intima/surgery , Chronic Disease , Female , Follow-Up Studies , Foot Ulcer/complications , Foot Ulcer/diagnosis , Humans , Ischemia/diagnosis , Ischemia/etiology , Middle Aged , Tibial Arteries/diagnostic imaging , Tomography, X-Ray Computed , Ultrasonography, Doppler, Duplex , Wound HealingABSTRACT
INTRODUCTION: This study aims to assess the patency, the clinical success and the limb-salvage rates of combined subintimal (SA) coupled to endoluminal angioplasty (EA) as the initial treatment of ischaemic inferior-limb ulcers in diabetic patients and to study the influence of other concurrent factors in the tissue-healing process. MATERIALS AND METHOD: Since September 2002 until December 2007, a consecutive series of 176 limbs with manifold ischaemic wounds in 161 diabetic patients were treated by associated multilevel angioplasties in a multidisciplinary 'diabetic-foot team' (a third-line diabetic-care institution integrating two departmental hospitals). There were 98 associated SA with EA procedures, 26 re-vascularisations by single SA technique and 52 others including selective multilevel EAs that were retrospectively reviewed. The mean follow-up period was 22.1 months (in the range of 1-50 months) by clinical and duplex evaluation (every 6 months). RESULTS: The initial technical success was noted in 149 limbs (84%). For the single or associated SA procedures, 102 of 124 procedures were successful (82%) and 145 of 150 of the miscellaneous EAs (96%) evinced an equally favourable outcome. The 27 initially failed endovascular procedures (22 SA and five EA) required 16 surgical re-vascularisation, eight adjuvant endovascular procedures besides three amputations. A total of 21 secondary and five tertiary angioplasties were equally necessary during the entire follow-up period of these patients. The 30-day survival rate was 99% (one patient died from myocardial infarction). In a intention-to-treat analysis, the cumulative primary and secondary patencies at 12, 24, 36 and 48 months were 62%, 45%, 41% and 38%, together with 80%, 69%, 66% and 66%, respectively. The aggregate clinical success rates at the same intervals were 86%, 77%, 70% and 69%, while the corresponding limb-salvage proportions showed 89%, 83%, 80% and 80%, respectively. The primary patency was negatively affected at 1 and 4 years by the length of the occluded segment (>10 cm) and the end-stage renal disease (ESRD) (p<0.0001). The limb-salvage rates were unfavourably influenced at the same periods by the extent of tissue defects (>3 cm), the ESRD and the presence of osteomyelitis. In addition, at 4 years, the age (>70 years), the accompanying peripheral neuropathy, the bedridden status and the presence of cardiac failure (left ventricular ejection fraction (LVEF)<30%) appeared equally as negative predictors (p<0.0001) for wound healing and limb rescue. CONCLUSION: Primary angioplasty represents a low aggressive and efficacious method to improve the healing process in diabetic ischaemic ulcers. However, beyond appropriate re-vascularisation, even repetitive if necessary, achieving satisfactory limb-salvage rates probably implies a multidisciplinary control of the presenting risk factors for wound healing as well.
Subject(s)
Angioplasty, Balloon/methods , Diabetic Foot/therapy , Ischemia/therapy , Age Factors , Aged , Aged, 80 and over , Female , Follow-Up Studies , Foot/blood supply , Heart Failure/complications , Humans , Limb Salvage/methods , Male , Middle Aged , Mobility Limitation , Patient Care Team , Peripheral Nervous System Diseases/complications , Recurrence , Retrospective Studies , Stents , Vascular Patency , Wound HealingABSTRACT
UNLABELLED: INTRODUCTION/AIM OF THE STUDY: To assess the influence of a multidisciplinary approach on the limb salvage rates in the treatment of patients suffering from diabetic ischaemic inferior limb ulcers. MATERIALS & METHOD: From September 2001 until March 2008, a consecutive series of 183 limbs with diabetic ischaemic wounds in 163 patients were treated by combined multi-level angioplasties as the primary revascularization approach in an institutional diabetic programme (two departmental hospitals). The avoidance of limb loss was retrospectively analyzed before and after the year 2005, as a landmark for implementing a "multidisciplinary diabetic foot clinic" in the routine daily care. RESULTS: Initial technical success for endovascular revascularization was noted in 152 limbs (83%). The aggregate limb salvage proportions at 12, 24, 32, 60 and 66 months (+/- SEM) were: 87% (+/- 2.8), 80% (+/- 3.9), 77% (+/- 4.4) and thereafter 77% (+/- 4.4), respectively. A comparison between the limb salvage rates before and after initiating the multidisciplinary group showed a significant difference (p = 0.040, CI: 1.040-5.311, HR: 2.35, Chi square = 4.22) with better results in the latest interval, employing effective team activity. No statistical deviation was found regarding the technique itself for revascularization at the same intervals (p = 0.381). CONCLUSION: Our experience suggests that limb salvage for diabetic ischaemic wounds may be favourably influenced by a co-ordinated multidisciplinary group. Although appropriate revascularization is crucial for limb rescue, a pluralist control of the attending risk factors influencing wound healing might be of matchless importance as well.
Subject(s)
Angioplasty, Balloon , Diabetic Foot/surgery , Limb Salvage/statistics & numerical data , Patient Care Team , Clinical Protocols , Humans , Retrospective Studies , Vascular Patency , Wound HealingSubject(s)
Echinodermata/metabolism , Metals/metabolism , Animals , Cadmium/analysis , Cadmium/metabolism , Chromium/analysis , Chromium/metabolism , Copper/analysis , Copper/metabolism , Digestive System/metabolism , Female , Gonads/metabolism , Iron/analysis , Iron/metabolism , Lead/analysis , Lead/metabolism , Male , Metals/analysis , Netherlands , Regression Analysis , Sex Factors , Spectrometry, X-Ray Emission , Titanium/analysis , Titanium/metabolism , Zinc/analysis , Zinc/metabolismABSTRACT
Seventeen kidneys removed from patients with renal carcinoma were submitted to ex vivo ultrasonography and then to serial pathological examination in an attempt to detect secondary tumours in apparently normal tissue. Ex vivo ultrasonography failed to reveal further tumours, but 2 lesions measuring 5 and 8 mm were found on pathological examination. These preliminary data suggest that intra-operative ultrasonography may be of little value in detecting secondary tumours in conservative surgery for renal carcinoma.
Subject(s)
Kidney Neoplasms/diagnostic imaging , Kidney Neoplasms/pathology , Neoplasms, Second Primary/diagnostic imaging , Humans , In Vitro Techniques , Intraoperative Period , Kidney Neoplasms/surgery , Neoplasms, Second Primary/pathology , Neoplasms, Second Primary/surgery , Nephrectomy , Prospective Studies , UltrasonographyABSTRACT
Neuroendocrine carcinomas of the prostate is rare and usually concern patients with an initial diagnosis of adenocarcinoma of the prostate which become refractory to hormonal treatment. Here is reported the case of a patient who presented with a primary neuroendocrine tumor of the prostate. A review of the literature shows the differences with usual adenocarcinoma and the diagnostic and therapeutic implications.
Subject(s)
Carcinoma, Neuroendocrine/pathology , Prostatic Neoplasms/pathology , Aged , Biomarkers, Tumor/analysis , Diagnosis, Differential , Humans , Male , Phosphopyruvate Hydratase/analysis , Prostate/pathologySubject(s)
Anastomosis, Surgical/methods , Prostatectomy/methods , Urethra/surgery , Urinary Bladder/surgery , Humans , MaleABSTRACT
We reviewed retrospectively a series of 58 patients with deeply invasive bladder cancer treated with fast neutron therapy (p(65) + Be) in order to evaluate its tolerance and side effects. Patients were divided into three groups according to treatment technique. Patients of group A received whole pelvis irradiation up to 50 Gy photon equivalent followed by a boost to the bladder up to 57-66 Gy photon equivalent (40-56 days). Group B patients were treated by a split course regimen of 30 Gy photon equivalent on the whole pelvis at 3-4 weeks interval (66-108 days). Group C patients, not suitable for radical treatment, received only 40-54 Gy photon equivalent (26-70 days). The overall 5-year actuarial survival rate was 30% (SE 8%). As expected, T stage was a statistically significant prognostic factor. The overall local control rate reached 21% at 4 years. Acute and late side effects were minimal to moderate. These results suggest that high-energy neutron beam treatment is at least as effective as photon beam treatment for bladder carcinoma, without a higher incidence of major side effects.